# Kymera Therapeutics, Inc.: Form SC 13D/A, filed Aug 22, 2024

- Company: [Kymera Therapeutics, Inc.](/companies/kymr.md) (CIK 1815442)
- Form: SC 13D/A
- Filed: 2024-08-22
- Accepted by EDGAR: Aug 22, 2024, 16:15 ET
- Period: not reported
- Accession: 0001104659-24-091998
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815442/000110465924091998/tm2422444d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815442/000110465924091998/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815442/000110465924091998/tm2422444d1_sc13da.htm

Filed Aug 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-091998. Last ingested by Listed: Oct 29, 2026, 07:17 ET. No prices; not investment advice.